Clinical Trials Browser

Phase 1/2 × Sarcoma × TH 302 × Clear all

NCT00742963 2025-05-13

Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma

Phase 1/2 Completed

107 enrolled 7 charts

Sarcoma